8-K//Current report
ORAMED PHARMACEUTICALS INC. 8-K
Accession 0001213900-25-111298
$ORMPCIK 0001176309operating
Filed
Nov 16, 7:00 PM ET
Accepted
Nov 17, 8:50 AM ET
Size
514.9 KB
Accession
0001213900-25-111298
Documents
- 8-Kea0265959-8k_oramed.htmPrimary
CURRENT REPORT
- EX-4.1ea026595901ex4-1_oramed.htm
RIGHTS AGREEMENT, DATED AS OF NOVEMBER 17, 2025, BETWEEN ORAMED PHARMACEUTICALS INC. AND CONTINENTAL STOCK TRANSFER & TRUST COMPANY, AS RIGHTS AGENT
- EX-99.1ea026595901ex99-1_oramed.htm
PRESS RELEASE DATED NOVEMBER 17, 2025
- EX-101.SCHormp-20251116.xsd
XBRL SCHEMA FILE
- EX-101.LABormp-20251116_lab.xml
XBRL LABEL FILE
- EX-101.PREormp-20251116_pre.xml
XBRL PRESENTATION FILE
- XMLR1.htm
IDEA: XBRL DOCUMENT
- XMLShow.js
IDEA: XBRL DOCUMENT
- XMLreport.css
IDEA: XBRL DOCUMENT
- XMLFilingSummary.xml
IDEA: XBRL DOCUMENT
- JSONMetaLinks.json
IDEA: XBRL DOCUMENT
- ZIP0001213900-25-111298-xbrl.zip
IDEA: XBRL DOCUMENT
- XMLea0265959-8k_oramed_htm.xml
IDEA: XBRL DOCUMENT
Issuer
ORAMED PHARMACEUTICALS INC.
CIK 0001176309
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001176309
Filing Metadata
- Form type
- 8-K
- Filed
- Nov 16, 7:00 PM ET
- Accepted
- Nov 17, 8:50 AM ET
- Size
- 514.9 KB